MITO

Stealth BioTherapeutics Corp. ADS

Delisted

MITO was delisted on the 15th of November, 2022.

10 hedge funds and large institutions have $835K invested in Stealth BioTherapeutics Corp. ADS in 2020 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
10
Holders Change
+1
Holders Change %
+11.11%
% of All Funds
0.2%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
1
Reduced
4
Closed
1
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
PM
1
Prosight Management
Texas
$346K -$47.4K -35,100 -12%
BBHC
2
Brown Brothers Harriman & Co
New York
$236K
Renaissance Technologies
3
Renaissance Technologies
New York
$121K -$225K -166,296 -65%
IC
4
Ikarian Capital
Texas
$50K
PC
5
PA Capital
Virginia
$23K -$6.33K -4,615 -22%
HF
6
HRT Financial
New York
$23K +$4.5K +3,341 +24%
Citadel Advisors
7
Citadel Advisors
Florida
$16K +$16K +12,189 New
UBS Group
8
UBS Group
Switzerland
$11K -$10.1K -7,198 -48%
Morgan Stanley
9
Morgan Stanley
New York
$8K
Osaic Holdings
10
Osaic Holdings
Arizona
$1K +$1K +604 New
Millennium Management
11
Millennium Management
New York
-$40K -21,974 Closed